Search Login Register

Mulibrey Nanism (Mulibrey Nanism Syndrome) Summary

Description: Growth failure from birth that is due to mutations in a gene (TRIM37) on chromosome 17q22-q23 which encodes a RING-B-box-coiled-coil protein.

Also Known As: Mulibrey Nanism Syndrome; Syndrome, Mulibrey Nanism; Muscle-Liver-Brain-Eye Nanism; Perheentupa Syndrome; Muscle Liver Brain Eye Nanism Show All >>

Networked: 15 relevant articles (1 outcomes, 1 trials/studies) for this Disease

Key Drugs and Agents for Mulibrey Nanism

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Natriuretic Peptides : 1 study in 1 result : IBA
  2. Ubiquitin : 2 results : IBA
  3. Growth Hormone (Somatotropin) : 2 results : IBA
  4. Silver : 2 results : IBA
  5. Proteins (Proteins, Gene) : 2 results : IBA
  6. Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase) : 1 result : IBA
  7. Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor) : 1 result : IBA
  8. Complementary DNA (cDNA) : 1 result : IBA
  9. Staphylococcal Protein A (A, Protein) : 1 result : IBA
  10. Glucose (Dextrose) : 1 result : FDA 175 Generic
Show All >>

Diseases Related to Mulibrey Nanism

  1. Constrictive Pericarditis
  2. Atrial Heart Septal Defects (Atrial Septal Defect)
  3. Heart Failure
  4. Growth Disorders
  5. Fetal Growth Retardation (Intrauterine Growth Retardation)
Show All >>

Key Therapies for Mulibrey Nanism

Efficacy Chart >>
  1. Pericardiectomy : 1 outcome in 3 results

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.